110 related articles for article (PubMed ID: 38847273)
1. Transcription factor FOXF2 promotes the development and progression of pancreatic cancer by targeting MSI2.
Zhong BH; Ma YT; Sun J; Tang JT; Dong M
Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38847273
[TBL] [Abstract][Full Text] [Related]
2. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
[TBL] [Abstract][Full Text] [Related]
3. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
[TBL] [Abstract][Full Text] [Related]
4. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway.
Zhou L; Sheng W; Jia C; Shi X; Cao R; Wang G; Lin Y; Zhu F; Dong Q; Dong M
J Cell Mol Med; 2020 Sep; 24(18):10560-10572. PubMed ID: 32779876
[TBL] [Abstract][Full Text] [Related]
5. FOXF2 Regulates PRUNE2 Transcription in the Pathogenesis of Colorectal Cancer.
Li T; Huang S; Yan W; Zhang Y; Guo Q
Technol Cancer Res Treat; 2022; 21():15330338221118717. PubMed ID: 35929169
[No Abstract] [Full Text] [Related]
6. Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/MSI2 axis in development of thyroid cancer.
Wang ZL; Wang C; Liu W; Ai ZL
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693087
[TBL] [Abstract][Full Text] [Related]
7. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
[TBL] [Abstract][Full Text] [Related]
8. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
9. ZC3HAV1 promotes the proliferation and metastasis via regulating KRAS in pancreatic cancer.
Huang W; Hua H; Xiao G; Yang X; Yang Q; Jin L
Aging (Albany NY); 2021 Jul; 13(14):18482-18497. PubMed ID: 34319912
[TBL] [Abstract][Full Text] [Related]
10. Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein.
Sheng W; Dong M; Chen C; Li Y; Liu Q; Dong Q
Oncotarget; 2017 Feb; 8(9):14359-14373. PubMed ID: 27092875
[TBL] [Abstract][Full Text] [Related]
11. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
[TBL] [Abstract][Full Text] [Related]
12. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Lo PK; Lee JS; Liang X; Sukumar S
Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-301b-3p induces proliferation and inhibits apoptosis in AML cells by targeting FOXF2 and regulating Wnt/β-catenin axis.
Lu Y; Zhong L; Luo X; Liu C; Dan W; Chu X; Wan P; Zhang Z; Wang X; Liu Z; Liu B
Mol Cell Probes; 2022 Jun; 63():101805. PubMed ID: 35259424
[TBL] [Abstract][Full Text] [Related]
14. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.
Hirata H; Ueno K; Shahryari V; Deng G; Tanaka Y; Tabatabai ZL; Hinoda Y; Dahiya R
PLoS One; 2013; 8(1):e55502. PubMed ID: 23383207
[TBL] [Abstract][Full Text] [Related]
16. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
[No Abstract] [Full Text] [Related]
17. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of microRNA-143-3p induces apoptosis and suppresses proliferation, invasion, and migration of papillary thyroid carcinoma cells by targeting MSI2.
Wang ZL; Wang C; Liu W; Ai ZL
Exp Mol Pathol; 2020 Feb; 112():104342. PubMed ID: 31738908
[TBL] [Abstract][Full Text] [Related]
19. Forkhead box F2/ Lysyl oxidase like 1 contribute to epithelial-mesenchymal transition and angiogenesis in thyroid cancer.
Fang H; Fu K; Shi P; Zhao Z; Yang F; Liu Y
Cell Signal; 2024 Jan; 113():110956. PubMed ID: 37918464
[TBL] [Abstract][Full Text] [Related]
20. Partner of NOB1 homolog transcriptionally activated by E2F transcription factor 1 promotes the malignant progression and inhibits ferroptosis of pancreatic cancer.
Yang Q; Yang B; Chen M
Chin J Physiol; 2023; 66(5):388-399. PubMed ID: 37929351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
